Furthermore, our findings illustrate that DIRAS3 inhibits EMT suppress NSCLC cell migration and invasion, which is in accordance with findings uncovered by Ouyang J et al. [38].. Here, DIRAS3 is linked to non-small cell lung carcinoma.